One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Prevalence of Elevated Lipoprotein(a) and its Association With Subclinical Atherosclerosis in 2.9 Million Chinese Adults
Lipoprotein(a) and Atherosclerosis: Not So Little Anymore With Bigger Data
An Oral PCSK9 Inhibitor for Treatment of Hypercholesterolemia: The PURSUIT Randomized Trial
Oral PCSK9 Inhibitors: Can Novel Therapies Overcome Barriers to Effective LDL-Cholesterol Management?
Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques: A PROSPECT II Substudy
Lipoprotein(a) and High-Risk Coronary Plaque: Dawn of a New Era in Assessment and Management of Vulnerable Plaque
Global Variation in Lipoprotein(a) Levels Among Patients With Coronary Heart Disease: Insights From the INTERASPIRE Study and Implications for Emerging Lp(a)-Lowering Therapies
Estimating the Global Impact of Lp(a) Across Different Thresholds and Populations: Challenges for Personalized Risk Prediction
Lipoprotein(a) Cardiovascular Risk Explained by LDL Cholesterol, Non-HDL Cholesterol, ApoB, or hsCRP Is Minimal
Amara Yad Image: The Relationship Between the Pulmonary Trunk and the Aorta
